Sahlgrenska University Hospital: Renewed WCMTM investment expands opportunities for clinician-researchers
Patient-centred clinical research is a key focus area as Sahlgrenska University Hospital strives to become one of Europe’s leading university hospitals in research and innovation. Through an expanded investment in the Wallenberg Centre for Molecular and Translational Medicine (WCMTM), an additional twelve clinical research leaders will be recruited from 2029 onwards.
The initiative is made possible through continued support from the Knut and Alice Wallenberg Foundation (KAW) in collaboration with Region Västra Götaland and the University of Gothenburg. Since its launch in 2015, the centre has recruited 13 clinical research leaders within Region Västra Götaland.
Clinical Research to Strengthen Future Healthcare
“Clinical research improves the quality of care, enables the development of new treatments, and contributes to securing long-term expertise and knowledge development throughout the region. We are delighted by KAW’s continued investment, which will give more clinicians the opportunity to conduct world-class clinical research,” says Caterina Finizia, Director of Research, Development, Education and Innovation (FoUUI) at Sahlgrenska University Hospital. Caterina is also professor at Sahlgrenska Academy.
Precision Medicine in Focus
Sahlgrenska University Hospital aims to be one of Europe’s leading university hospitals by 2032. According to Hospital Director Boubou Hallberg, achieving this goal will require both advances in precision medicine—where treatments and diagnostics are tailored to the individual patient—and a stronger data-driven approach to healthcare.
“Through collaboration in research centres and research environments, we aim to translate scientific discoveries into tangible patient benefits more rapidly, while at the same time strengthening the healthcare of the future,” says Boubou Hallberg.
Several research areas are already at the forefront of precision medicine. Hallberg highlights neurodegenerative diseases, advanced melanoma treatments, gut microbiota research, and pregnancy-related complications such as preeclampsia as examples—fields where WCMTM researchers are conducting internationally competitive research.
A Data-Driven Approach
Another key component is the ongoing digital and data-driven transformation of healthcare. By using health data more systematically, the hospital aims to better understand which patients will benefit from specific treatments and diagnostic methods, while also ensuring more efficient use of healthcare resources.
World-Class Research Environments
Sahlgrenska is also investing in major research and innovation environments such as Sahlgrenska Life, where healthcare, research, infrastructure, education and the life science industry come together to create better conditions for translational research and innovation. The goal is to establish world-class environments where new treatments and technologies can be developed and implemented in healthcare more rapidly.
“To succeed, we need strong collaboration with academia and industry, both nationally and internationally. Continuing our partnership through WCMTM and building strong clinical research environments in Gothenburg is aligned with the hospital’s vision,” says Boubou Hallberg.
